Doha Declaration and Compulsory License for Access to Medicines
The Doha Declaration provides for access to medicines particularly by simplifying the compulsory licensing (CL) clause. This paper tries to provide a comprehensive review of the working of CL in the developed and developing countries with some useful case studies. [GIDR WP No. 184].
When requesting a correction, please mention this item's handle: RePEc:ess:wpaper:id:2216. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Padma Prakash)
If references are entirely missing, you can add them using this form.